Shanghai Tongren Hospital
Changning, Shanghai Municipality, 200336, China
NCT Number: NCT06583564
Previous studies of Indocyanine green (ICG) in colorectal surgery have focused on lymphatic mapping, lymph node detection, and the number of harvested lymph nodes. However, relatively few studies have evaluated the outcomes of this imaging technology, especially the prognosis following of colorectal cancer resection. The present study assessed the prognosis of stage III colorectal cancer patients following ICG fluorescence-guided surgery as compared to conventional surgery without the use of ICG Fluorescence imaging
Interested in participating?
Request Info18 year and older
All sexes
Interventional
Not applicable
Changning, Shanghai Municipality, 200336, China
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
All patients underwent standard complete mesocolic excision (CME) or total mesorectal excision (TME) with curable purpose using ICG lymphangiography procedure
Time frame: From radical surgery to the end of follow-up ,up to 36 months
the rate of of no recurrence or metastasis after 3 years from radical surgery
Time frame: From radical surgery to the end of perioperative period at 1 month
the number of harvested lymph nodes of radical surgery
Time frame: From radical surgery to the end of perioperative period at 1 month
Postoperative complications ICG-related complications, surgery-related complications, and systemic complications. Postoperative complications were graded according to the Clavien-Dindo system
Time frame: From radical surgery to the end of follow-up ,up to 36 months
the rate of 3 years overall survival after radical surgery
Shanghai Tong Ren Hospital
Other
A Single Center Randomized Controlled Study of the Prognosis After Indocyanine Green Fluorescence-guided Radical Surgery in Colorectal Cancer Patients of Stage III
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07225309
Breast Cancer, Breast Cancer Stage III
New York, United States
View Trial DetailsNCT04486378
Colonic Diseases, Colorectal Cancer Stage II
Greenbrae, California, United States
View Trial DetailsNCT06342440
Colonic Diseases, Colonic Neoplasms
Monrovia, California, United States
View Trial DetailsNCT06314958
Colonic Diseases, Colorectal Adenocarcinoma
Monrovia, California, United States
View Trial Details